TerminatedNCT05965401
Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents
Interventional studyAges 12–17CanadaDepression
Understand this study
Who could participate?
Listed age limits: 12 years to 17 years.
- Listed locations
- CalgarySee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 25, 2023
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 11
- Sponsor
- University of Calgary
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other
- Locations
- Canada
- Age range
- From 12 Years to 17 Years
- Official registry ID
- NCT05965401
- Official title
Show the full official title
Pharmacogenetic-Guided Antidepressant Prescribing (PGx-GAP) in Adolescents
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Calgary
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Calgary, a university.
Who can participate?
Listed age limits: 12 years to 17 years.
Is this study still recruiting?
The registry lists this study as terminated.
